top of page
EpiFollow
Following the development of children born to mothers with epilepsy
This research helps us learn more about how children grow and develop after being exposed to anti-seizure medicines during pregnancy.
EpiFollow Video
About EpiFollow
EpiFollow is part of the EpiSafe research programme. It follows up with children, now aged 8 to 14, whose mothers took part in the NaME or EMPiRE studies and used anti-seizure medication during pregnancy.
What does it involve?
One-Time Visit
Flexible location
at home, school,
or clinic
Child Activities
Fun tasks that look at memory, thinking, attention & communication
Parent Questionnaires
Questions about your child’s behaviour, emotions & social skills
Parent Insights (Optional)
Short IQ task to help understand the full picture
Share Your Story (Optional)
Some families may be invited to speak about parenting with epilepsy
You’ll receive a brief written summary of your child’s assessment to keep and a £25 voucher as a Thank You
By taking part, you are helping
Many epilepsy medicines are essential to help women stay well during pregnancy, but we still don’t fully understand if or how they might affect children as they grow. EpiFollow is the largest study of its kind in the UK and will help us build better guidance for families in future.
Understand how children develop over time
Learn how medications during pregnancy may influence development
Improve guidance and care for future families
What if I have questions?
Reach out to us at epi_follow@manchester.ac.uk or 0161 306 1700
Thank You
By sharing your time and experiences, you are helping us learn and improve care for other families in the future.
bottom of page